MeSH D000086382 - covid-19
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D000086382:
Covid-19
D000094024:Post-acute covid-19 syndrome
0 Companies
0 Drugs
Success rate
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Roche | Casirivimab, Imdevimab | Ronapreve | 2021-11-12 | $1,999.675 M | Q2/22-Q1/23 |
Clinical Trials
Historical Success Rate
Phase 1
87%88/101
Phase 2
59%191/325
Phase 3
29%67/233
Approved: 4Overall Success rate: 15%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use